Perjeta Biosimilar Pebrilzo Gets Strong Boost After Settlement
A Perjeta biosimilar gets dates: Biocon says its Genentech settlement allows Pebrilzo in the EU and UK in Q1 2027 and the US in Q3 2028, subject to approvals.
Tag: pertuzumab biosimilar
Read More